Farkas K Christopher

CW CFO Farkas sells 1,265 shares at $689.69; holds 4,253 shares post-sale as stock near 52-week high

Farkas K Christopher, Executive VP and CFO, sold 1,265 shares on 2026-03-18 at $689.69, reducing his holdings by 22.9% and generating $872,457.85 in proceeds. The sale occurred near the 52-week high of $726.48 (current price $691.62 is 4.8% below that peak). His same-ticker history at CW shows a pattern of regular selling activity: five prior trades at this ticker, with only 0 of 2 measurable prior 90-day outcomes classified as well-timed (the most recent measurable sale on 2025-11-11 declined 1.5% in 30 days but rose 13.1% over 90 days, indicating poorly timed execution). Cross-ticker, his 7 prior sells averaged a 0.00% well-timed rate over 90 days. The company trades at a P/E of 46.86 with strong fundamentals: $869.2M in latest quarterly revenue, $124.8M net income, and 12.1% annual revenue growth, suggesting valuation may be elevated relative to near-term earnings power. The concentrated selling pattern at a historically high price point merits monitoring, though lack of measurable recent comparative outcomes limits definitive conclusions about timing intent.

CFO Farkas sells 918 CW shares at $677.46 (total $621.9K); stock up 27.4% in 90 days, P/E 46.81.

Farkas K Christopher, Executive VP and CFO, sold 918 shares of Curtiss Wright at $677.46, reducing his holdings from 6,436 to 5,518 shares. The sale occurred as the stock has appreciated significantly in the near term (up 27.4% over 90 days, with a current price of $690.94 just 4.9% below the 52-week high), positioning the transaction near a peak in recent momentum. At his prior five trades at this ticker, Farkas achieved a 0% well-timed rate on sells at the 90-day measurement mark, indicating his historical sales at CW have consistently been followed by further stock appreciation rather than declines. The company shows solid fundamentals with annual revenue growth of +12.1% and net income of $124.8M, though valuation metrics appear elevated at a P/E of 46.81. This sale pattern—disposing of shares during a strong uptrend without a track record of well-timed exits at this ticker—presents a data point for investor review.

CFO Farkas sells 3,105 shares (42.2% of holdings) at $694.51, reducing stake from 7.4K to 4.3K shares

CFO Christopher Farkas executed a substantial open-market sale of 3,105 shares on 2026-02-18 at $694.51, reducing his holdings by 42.2% in a single transaction. The sale price was at the 52-week high ($690.86), and the stock has appreciated 28.9% over 90 days and 4.1% over 30 days. His prior trades at Curtiss Wright show mixed timing outcomes: of 4 measurable prior trades at this ticker, none were well-timed at the 90-day mark. Cross-ticker, his 5 prior sales averaged 18.1% gains over 90 days, suggesting sells have historically been followed by stock appreciation rather than declines. The 42.2% reduction in position size represents a material reshaping of his stake in the company.

CFO Farkas K Christopher sold 2,665 shares of CW at $626.33 for $1,669,169.45; reduced holdings by 26.6% (from 10,023 to 7,358 shares)

Farkas K Christopher, Executive VP and CFO, executed a material reduction of his CW position, divesting 2,665 shares (26.6% of his pre-transaction holdings) at $626.33. The stock currently trades at $618.60, down 8.3% from its 52-week high of $674.79, suggesting the sale occurred near recent price strength. His prior trading history at CW shows mixed timing: of 5 prior trades at this ticker, only 1 of 4 measurable outcomes was well-timed at the 90-day mark, and his recent sell on 2025-11-11 saw prices decline 1.5% within 30 days. Cross-ticker, his sells have averaged a 90-day well-timed rate of 0.00%, indicating his exit decisions historically have not preceded stock declines. Curtiss Wright's fundamentals remain solid (P/E 49.06, +9.7% annual revenue growth, $124.8M net income), but the CFO's substantial single-transaction divestment warrants attention for its magnitude and pattern relative to his prior trading record.

CFO Farkas sold 5,047 shares of CW at $577.91 for $2.9M, reducing holdings by -54.4% to 4,236 shares

Farkas K Christopher, Vice President and CFO, executed a substantial sale of 5,047 shares at $577.91 on 2025-11-11, reducing his holdings by -54.4% from 9,283 to 4,236 shares. The sale occurred near the 52-week high of $601.78 (within -9.2% of peak), coinciding with positive recent momentum—the stock returned +12.1% over 90 days and +18.6% following his prior buy on 2025-01-06. Across his same-ticker history at CW, the timing pattern has been mixed: only 1 of 5 prior trades were well-timed at the 90-day mark, including his most recent 2025-05-01 sell that saw +25.8% 30-day and +41.8% 90-day returns (poorly timed). The company shows solid fundamentals with $869.2M quarterly revenue, +9.7% annual growth, and a P/E of 43.31, but this CFO-level reduction in personal stake warrants attention as a data point in ongoing position management.

CFO Christopher Farkas sold 4,780 CW shares at $350.00 on 2025-05-01 ($1.7M), reducing holdings 34.1%; stock up 8.6% in 30 days.

Farkas K Christopher, VP and CFO, executed a substantial sale of 4,780 shares worth $1,673,000.00, reducing his CW holdings from 14,033 to 9,253 shares. The $1.7M transaction represents a material reduction of 34.1% in his position. Context: the stock has gained 8.6% in the 30 days following the May 1 sale and currently trades at $350.28, just 10.1% below its 52-week high of $389.49. His cross-ticker track record shows prior sells averaged +12.8% return at the 90-day mark with a 0% well-timed rate—suggesting his past sales have coincided with subsequent stock appreciation rather than declines. At the same ticker, his prior sale on 2025-02-05 experienced a 30-day decline of -9.3%, though longer-term outcome is unmeasurable. The company trades at a P/E of 28.83 with solid fundamentals: $798.9M quarterly revenue, $111.2M net income, and 9.7% annual revenue growth. The timing and magnitude of this sale warrant observation given the pattern of prior sells failing to precede price declines and the stock's recent momentum.

CFO Christopher Farkas sells 2,453 shares of CW at $347.00 for $851,191.00; retains 12,712 shares post-sale.

Christopher Farkas, Vice President and CFO, sold 2,453 shares on 2025-02-05 at $347.00, reducing his holdings by 16.2% from 15,165 to 12,712 shares. The stock closed at $350.93 on filing date, approximately 1.1% above the transaction price, and remains 9.9% below its 52-week high of $389.49. Across his prior five trades at CW, Farkas's sole prior sale (2024-03-14) generated a 90-day return of +12.8%, meaning the stock rose after he sold, indicating that earlier sale was not well-timed. His cross-ticker track record across all open-market activity shows four prior buys with strong returns (90d: +44.8% average, 100% win rate), but only one prior sell with a 90d well-timed rate of 0.00%, suggesting his sells have not reliably preceded price declines. The stock trades at a P/E of 32.71 with revenue growth of +11.3% year-over-year, characteristics that do not inherently signal distress.

CW CFO Farkas buys 30 shares at $304.12; 6 other insiders bought within 14 days; strong CW track record (90d +44.8%)

Farkas K Christopher, Vice President and CFO, purchased 30 shares of Curtiss Wright at $304.12 on 2025-01-06, bringing holdings to 9,253 shares. This purchase is part of a broader cluster: 6 other insiders also bought within the past 14 days. At this same ticker, Farkas's prior buy on 2024-07-03 returned +44.8% over 90 days, establishing a pattern of well-timed accumulation at CW. The stock is currently at $351.23, down 6.6% over 30 days but up 3.9% over 90 days, while trading at a P/E of 32.73 with $798.9M in latest quarterly revenue and +11.3% annual growth. The multi-insider buy cluster during a recent pullback (-9.8% from 52-week high of $389.49) warrants monitoring of whether this reflects management confidence in near-term recovery or operational developments.

CW CFO Farkas buys 51 shares at $232.62 amid cluster buy pattern; 4 other insiders bought in past 14 days

Farkas K Christopher, Vice President and CFO of Curtiss Wright, purchased 51 shares at $232.62 on 2024-07-03, increasing his holdings from 9,172 to 9,223 shares. This transaction coincides with a broader cluster buy pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated or independently motivated accumulation at this price level. Farkas's cross-ticker track record shows 2 prior buys with an average 90-day return of +30.3% and a 100% win rate, though his same-ticker history at CW is more mixed—2 of 3 prior trades were well-timed at the 90-day mark, including a prior buy on 2024-01-04 that returned +35.9% over 90 days. The current stock price of $271.24 sits 4.9% below its 52-week high of $285.21 and up 4.7% over the past 90 days, positioning this buy within a moderately elevated valuation context (P/E 27.76). The cluster dynamic and Farkas's demonstrated success timing CW buys warrant attention as confirmatory signals of insider perspective on near-term value.